Key Takeaways U.S. equities were mixed at midday, slowed by new Chinese tariffs on U.S. goods and weak tech results.Alphabet ...
Investor's Business Daily on MSN32m
GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 BillionGSK stock rocketed Wednesday after the pharma titan raised its 2031 sales outlook to north of $50 billion.Please watch the ...
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback